Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,412,077
+$10,084 QoQ
Shares Held
15,391
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#392
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HEADINVEST, LLC holds $15,409,722 across 8 Drug Manufacturers - General names. NVS ranks #2 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
88,590 | $4,247,004 | |
| 2 | NVS |
Novartis AG
This page
|
15,391 | $2,412,077 | |
| 3 | ABBV |
AbbVie Inc.
|
9,300 | $2,340,252 | |
| 4 | LLY |
ELI LILLY & Co
|
1,634 | $1,959,868 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,769 | $1,897,816 | |
| 6 | JNJ |
Johnson & Johnson
|
7,126 | $1,809,790 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,791 | $391,297 | |
| 8 | AMGN |
Amgen Inc
|
971 | $351,618 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,412,077 | 15,391 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,401,993 | 15,725 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,251,692 | 16,332 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,118,011 | 16,516 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,043,132 | 16,884 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,972,192 | 17,691 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,737,080 | 17,851 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $2,053,222 | 17,851 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,913,937 | 17,978 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,739,011 | 17,978 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $1,818,974 | 18,015 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,843,971 | 18,103 | Shares | Sole | 2023-12-11 | |
| 2023-06-30 | $1,826,773 | 18,103 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $1,715,432 | 18,646 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $1,702,723 | 18,769 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,441,529 | 18,965 | Shares | Sole | 2022-12-28 | |
| 2022-06-30 | $1,632,274 | 19,310 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,594,856 | 18,175 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,571,486 | 17,966 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,228,826 | 15,026 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,376,720 | 15,089 | Shares | Sole | 2021-08-30 | |
| 2021-03-31 | $1,272,797 | 14,890 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,387,743 | 14,696 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,117,609 | 12,852 | Shares | Sole | 2020-11-24 | |
| 2020-06-30 | $1,131,227 | 12,952 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,068,387 | 12,958 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||